NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
55,648,941
Share change
+1,219,994
Total reported value
$82,330,815
Put/Call ratio
23400%
Price per share
$1.48
Number of holders
84
Value change
+$1,677,502
Number of buys
41
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q2 2014

As of 30 Jun 2014, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,648,941 shares. The largest 10 holders included Platinum Management (NY) LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, COMMERZBANK AKTIENGESELLSCHAFT /FI, NOMURA HOLDINGS INC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT CO LLP, State Street Corp, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP. This page lists 84 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.